Stanford Health Care’s Janjri Desai, Pharm.D., says pharmacists improve outcomes but often can’t bill for it, making billing parity key to growing services.
|Articles|December 1, 2004
FDA safety oversight under scrutiny
Recent scares about suicidality linked to antidepressants and painkillers intensifying interest in policies to ensure the safe use.
Advertisement
Advertisement
Related to this article
Stanford Health Care’s Janjri Desai, Pharm.D., says pharmacy should be treated as a clinical service line, not just a 340B financial workhorse.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Medicaid can't opt out of gene therapies, so planning matters more, says Katelyn Meyer, Pharm.D. | AMCP Nexus 2026
2
How common is atopic dermatitis in the US? Not nearly as common as other research has shown, according to this study
3
5 things you should know about the midterms and healthcare
4
Lower fitness tied to persistent fatty liver disease in teen boys with obesity
5